SCHEMBL21291207

SCHEMBL21291207

CCOC(=O)c1cc(C(C)O)cc2nccn12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 6/20 0.40
HPGD P15428 5/20 0.40
GLA P06280 2/20 0.40
GAA P10253 2/20 0.40
TSHR P16473 3/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB2 P47870 2/20 0.38
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
LMNA P02545 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2C9 P11712 1/20 0.38
ABCB11 O95342 1/20 0.38
GABRA2 P47869 1/20 0.38
HSD17B10 Q99714 3/20 0.37
OGA O60502 1/20 0.36
JMJD6 Q6NYC1 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19697737 0.91 ALDH1A1 (0.41) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL17437968 0.81 KDM4E (0.50) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL19697536 0.81 KDM4E (0.33) KDM4EALDH1A1GAA
SCHEMBL19697629 0.80 ALDH1A1 (0.42) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL21291210 0.79 ALDH1A1 (0.41) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL19697666 0.77 ALDH1A1 (0.40) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL19697726 0.77 ALDH1A1 (0.40) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL19697643 0.74 KDM4E (0.51) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL4125150 0.74 GAA (0.48) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL14739536 0.71 MAPK1 (0.42) KDM4EALDH1A1HPGDGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190256509-A1 HISTONE DEMETHYLASE INHIBITORS CHRYSALIS INC (US) 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256509-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM6B, KDM2A KDM4E 12/4885ALDH1A1 1564/4885HPGD 1945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.